ISRCTN54371254已完成不适用
High dose immunoablation and autologous haematopoietic stem cell transplantation versus monthly intravenous pulse therapy
European Group for Bone Marrow Transplantation0 个研究点目标入组 156 人开始时间: 2005年10月19日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 156
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Patients with diffuse systemic sclerosis, aged 16 to 65 years, and:
- •1. Disease duration four years or less, plus evidence of heart, lung or kidney involvement, plus skin score of 15 or more, or
- •2. Disease duration two years or less, plus evidence of an acute phase reaction in blood, plus skin score 20 or more
排除标准
- •Patients with concomitant severe disease, extensive pretreatment according to predefined criteria with cyclophosphamide are excluded.
研究者
相似试验
进行中(未招募)
不适用
High dose immunoablation and autologous hematopoietic stem cell transplantation versus monthly intravenous pulse therapy cyclophosphamide in severe systemic sclerosis ( ‘ASTIS’-TRIAL: Autologous Stem Cell Transplantation International Scleroderma Trial) - ASTISSevere systemic sclerosisMedDRA version: 9.1Level: LLTClassification code 10042953Term: Systemic sclerosisEUCTR2006-004598-83-GBEBMT (European group for Blood and Marrow Transplantation)150
招募中
不适用
Autologous Stem cell Transplantation International Scleroderma ('ASTIS') Trial.Systemic sclerosis.NL-OMON23346EBMT/EULAR Working Party Autoimmune Diseases.200
进行中(未招募)
不适用
Immunotherapy by autologous peripheral blood mononuclear cells and GM-CSF for hepatocellular carcinoma undergoing radiofrequency thermal ablation - HCC thermal ablation and immunotherapy combined treatmentpatients with hepatocellular carcinomaMedDRA version: 9.1Level: LLTClassification code 10059319Term: Hepatic cancer stage IIEUCTR2008-003925-17-ITAZIENDA OSPEDALIERA DI PARMA
已完成
不适用
Transplantation for Patients With Chronic Lymphocytic LeukemiaLeukemia, Lymphocytic, ChronicNCT00186303Stanford University28
进行中(未招募)
不适用
Allogeneic Haematopoietic Cell Transplantation Using a Non-myeloablative Preparative Regimen of Total Lymphoid Irradiation and Anti-Thymocyte Globulin for Patients with Refractory ?Triple Negative? Breast Cancer - NDPatients with Refractory ?Triple Negative? Breast CancerMedDRA version: 9.1Level: LLTClassification code 10006187Term: Breast cancerEUCTR2008-006262-28-ITISTITUTO EUROPEO DI ONCOLOGIA
